Works matching DE "BUSPIRONE"

Results: 293

The behavioural effects of the serotonin 1A receptor agonist buspirone on cognition and emotional processing in healthy volunteers.

Published in:

Psychopharmacology, 2025, v. 242, n. 8, p. 1859, doi. 10.1007/s00213-025-06770-6

By:

Smith, Alexander L. W.;
Hamilton, Sorcha;
Murphy, Susannah E.;
Cowen, Philip J.;
Harmer, Catherine J.

Publication type:

Article

Serotonin Geri Alım Engelleyicilerinin Neden Olduğu Bruksizm: İki Olgu.

Published in:

2009

By:

Ak, Mehmet;
Gülsün, Murat;
Uzun, Özcan;
Gümüş, Hasan Önder

Publication type:

Case Study

Anxiety associated with ciprofloxacin.

Published in:

Brown University Psychopharmacology Update, 2018, v. 29, n. 2, p. 2, doi. 10.1002/pu.30294

By:

Lam, Y. W. Francis

Publication type:

Article

Buspirone attenuated methotrexate‐induced hippocampal toxicity in rats by regulating Nrf2/HO‐1, PPAR‐γ, NF‐κB/nNOS, and ROS/NLRP3/caspase‐1 signaling pathways.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 9, p. 1, doi. 10.1002/jbt.23414

By:

Althagafy, Hanan S.;
Sharawi, Zeina W.;
Batawi, Ashwaq H.;
Almohaimeed, Hailah M.;
Al‐Thubiani, Wafa S.;
Hassanein, Emad H. M.;
Rateb, Amal

Publication type:

Article

Assessing the Efficacy of Specific Cerebellomodulatory Drugs for Use as Therapy for Spinocerebellar Ataxia Type 1.

Published in:

Cerebellum, 2013, v. 12, n. 1, p. 74, doi. 10.1007/s12311-012-0399-x

By:

Nag, Nupur;
Tarlac, Volga;
Storey, Elsdon

Publication type:

Article

Buspirone Enhances Cell Survival and Preserves Structural Integrity during Oxidative Injury to the Retinal Pigment Epithelium.

Published in:

Antioxidants, 2023, v. 12, n. 12, p. 2129, doi. 10.3390/antiox12122129

By:

Biswal, Manas R.;
Paulson, Ryan J.;
Vichare, Riddhi;
Lewin, Alfred S.

Publication type:

Article

Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 5, p. 610, doi. 10.1111/j.1365-2710.2012.01344.x

By:

Morrison, E. K.;
Rowe, A. S.

Publication type:

Article

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade.

Published in:

Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00710

By:

Torrisi, Sebastiano Alfio;
Salomone, Salvatore;
Geraci, Federica;
Caraci, Filippo;
Bucolo, Claudio;
Drago, Filippo;
Leggio, Gian Marco

Publication type:

Article

Changes in fatalities due to overdose of anxiolytic and sedative drugs in the UK (1983-1999).

Published in:

2004

By:

Buckley, Nicholas A.;
McManus, Peter R.

Publication type:

journal article

Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: Evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss.

Published in:

Nordic Journal of Psychiatry, 2005, v. 59, n. 3, p. 205, doi. 10.1080/08039480510027689

By:

Andersen, Torben Houman;
Bech, Per;
Larsen, Niels-Erik

Publication type:

Article

Aggregation of Gold Nanoparticles for Spectrophotometric Determination of Bisoprolol Hemifumarate, Buspirone HCl and Doxazosin Mesylate.

Published in:

Nano Biomedicine & Engineering, 2019, v. 11, n. 1, p. 1, doi. 10.5101/nbe.v11i1.p1-10

By:

Ayad, Magda Mohamed;
Abdellatef, Hisham Ezzat;
Hosny, Mervat Mohamed;
Kabil, Naglaa Abdel-Sattar

Publication type:

Article

Placebo Medication Use for Behavior Management in an Adult with Autism.

Published in:

Education & Training in Autism & Developmental Disabilities, 2011, v. 46, n. 3, p. 470

By:

Kroeger, K. A.;
Brown, Jennifer

Publication type:

Article

EXTENDING THERAPEUTIC UTILITY OF PSYCHOSTIMULANTS.

Published in:

2012

By:

IKRAM, HUMA;
CHOUDHRY, ADNAN MAQSOOD;
HALEEM, DARAKHSHAN JABEEN

Publication type:

Editorial

Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series.

Published in:

Journal of Autism & Developmental Disorders, 2020, v. 50, n. 2, p. 676, doi. 10.1007/s10803-019-04301-9

By:

Thom, Robyn P.;
Keary, Christopher J.;
Waxler, Jessica L.;
Pober, Barbara R.;
McDougle, Christopher J.

Publication type:

Article

Multidisciplinary Assessment and Treatment of Self-Injurious Behavior in Autism Spectrum Disorder and Intellectual Disability: Integration of Psychological and Biological Theory and Approach.

Published in:

Journal of Autism & Developmental Disorders, 2015, v. 45, n. 6, p. 1541, doi. 10.1007/s10803-014-2307-3

By:

Minshawi, Noha;
Hurwitz, Sarah;
Morriss, Danielle;
McDougle, Christopher

Publication type:

Article

Effects on behavioural variables of oral versus transdermal buspirone administration in cats displaying urine marking.

Published in:

Journal of Applied Animal Research, 2016, v. 44, n. 1, p. 454, doi. 10.1080/09712119.2015.1091335

By:

Chávez, Gonzalo;
Pardo, Paulina;
Ubilla, María José;
Marín, María Paz

Publication type:

Article

A triple-blinded, randomized, placebo-controlled trial to examine the efficacy of buspirone added to typical antipsychotic drugs in patients with chronic schizophrenia.

Published in:

Journal of Research in Medical Sciences, 2015, v. 20, n. 2, p. 140

By:

Sheikhmoonesi, Fatemeh;
Zarghami, Mehran;
Bahari Saravi, Seyyedeh Fatemeh;
Khalilian, Alireza;
Ala, Shahram

Publication type:

Article

Somatodendritic 5-hydroxytryptamine1A(5-HT1A) autoreceptor function in major depression as assessed using the shift in electroencephalographic frequency spectrum with buspirone.

Published in:

Psychological Medicine, 2014, v. 44, n. 4, p. 767, doi. 10.1017/S0033291713001475

By:

McAllister-Williams, R. H.;
Alhaj, H. A.;
Massey, A.;
Pankiv, J.;
Reckermann, U.

Publication type:

Article

Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.

Published in:

Acta Psychiatrica Scandinavica, 2012, v. 125, n. 4, p. 342, doi. 10.1111/j.1600-0447.2011.01791.x

By:

Bech, P.;
Fava, M.;
Trivedi, M. H.;
Wisniewski, S. R.;
Rush, A. J.

Publication type:

Article

Disruption of Epithalamic Left-Right Asymmetry Increases Anxiety in Zebrafish.

Published in:

Journal of Neuroscience, 2015, v. 35, n. 48, p. 15847, doi. 10.1523/JNEUROSCI.2593-15.2015

By:

Facchin, Lucilla;
Duboué, Erik R.;
Halpern, Marnie E.

Publication type:

Article

A case of a pediatric patient after a large ingestion of buspirone.

Published in:

2021

By:

Krenz, James R.;
Chary, Anita;
Schwartz, Kevin R.;
Hayes, Bryan D.;
O'Brien, Michael E.

Publication type:

Letter

Effects of acute buspirone administration on inhibitory control and sexual discounting in cocaine users.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 1, p. n/a, doi. 10.1002/hup.2567

By:

Strickland, Justin C.;
Bolin, B. Levi;
Romanelli, Michael R.;
Rush, Craig R.;
Stoops, William W.

Publication type:

Article

Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT1A receptor agonist.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2009, v. 24, n. 6, p. 437

By:

Piškulić, Danijela;
Olver, James S.;
Maruff, Paul;
Norman, Trevor R.

Publication type:

Article

An open trial of buspirone in the treatment of attention-deficit disorder.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2003, v. 18, n. 6, p. 489, doi. 10.1002/hup.511

By:

Helmut Niederhofer

Publication type:

Article

Effects of anxiolytics on memory.

Published in:

Human Psychopharmacology: Clinical & Experimental, 1999, v. 14, p. S72, doi. 10.1002/(sici)1099-1077(199908)14:1+<s72::aid-hup120>3.3.co;2-s

By:

Curran, H. Valerie

Publication type:

Article

Anxiolytic effect of hydroxyzine: a double-blind trial versus placebo and buspirone.

Published in:

Human Psychopharmacology: Clinical & Experimental, 1999, v. 14, p. S94, doi. 10.1002/(sici)1099-1077(199908)14:1+<s94::aid-hup123>3.3.co;2-b

By:

Lader, Malcolm

Publication type:

Article

Overlap of Buspirone with Lorazepam, Diazepam and Bromazepam in Patients with Generalized Anxiety Disorder: Findings from a Controlled, Multicentre, Double-Blind Study.

Published in:

Human Psychopharmacology: Clinical & Experimental, 1994, v. 9, n. 6, p. 409, doi. 10.1002/hup.470090604

By:

Sacchetti, E.;
Zerbini, O.;
Banfi, F.;
Tansella, M.

Publication type:

Article

Topographic Pharmaco-EEG Mapping of Increasing Doses of Buspirone and its Comparison with Diazepam.

Published in:

Human Psychopharmacology: Clinical & Experimental, 1994, v. 9, n. 2, p. 101, doi. 10.1002/hup.470090203

By:

Barbanoj, M. J.;
Anderer, P.;
Antonijoan, R. M.;
Torrent, J.;
Saletu, B.;
Jané, F.

Publication type:

Article

Buspirone: Really Non-Effective in Japanese patients with anxiety neurosis?

Published in:

1993

By:

Okada, Fummiko

Publication type:

Letter

Repeated Administration of Buspirone: Absence of Pharmacodynamic or Pharmacokinetic Interaction with Triazolam.

Published in:

Human Psychopharmacology: Clinical & Experimental, 1993, v. 8, n. 2, p. 117, doi. 10.1002/hup.470080205

By:

Boulenger, Jean-Philippe;
Gram, Lars F.;
Jolicoeur, François B.;
Zarifian, Edouard

Publication type:

Article

An Open Study of Buspirone in Octogenarians with Anxiety.

Published in:

Human Psychopharmacology: Clinical & Experimental, 1989, v. 4, n. 1, p. 51, doi. 10.1002/hup.470040109

By:

Levine, Sidney;
Napoliello, Michael J.;
Domantay, Antonio G.

Publication type:

Article

Convulsant Actions of the Anxiolytic Buspirone in Combination with Antidepressants.

Published in:

Human Psychopharmacology: Clinical & Experimental, 1988, v. 3, n. 2, p. 145, doi. 10.1002/hup.470030212

By:

File, Sandra E.

Publication type:

Article

Serotonergic agonists inhibit calcium-activated potassium and voltage-dependent sodium currents in rat taste receptor cells.

Published in:

2000

By:

Herness, M.S.;
Chen, Y.

Publication type:

journal article

Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.

Published in:

2016

By:

Peoples, Anita;
Bushunow, Peter;
Garland, Sheila;
Heckler, Charles;
Roscoe, Joseph;
Peppone, Luke;
Dudgeon, Deborah;
Kirshner, Jeffrey;
Banerjee, Tarit;
Hopkins, Judith;
Dakhil, Shaker;
Flannery, Marie;
Morrow, Gary;
Peoples, Anita R;
Bushunow, Peter W;
Garland, Sheila N;
Heckler, Charles E;
Roscoe, Joseph A;
Peppone, Luke L;
Dudgeon, Deborah J

Publication type:

journal article

Intravenous buspirone for the prevention of postoperative nausea and vomiting.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 11, p. 1465, doi. 10.1007/s00228-012-1284-8

By:

Kranke, Peter;
Röhm, Kerstin;
Diemunsch, Pierre;
Gan, Tong;
Apfel, Christian;
Eberhart, Leopold;
Minkowitz, Harold;
Wallenborn, Jan;
Chassard, Dominique;
Lebuffe, Gilles;
Fox, Gabriel;
Tramèr, Martin

Publication type:

Article

Involvement of 5-HT 1A Receptors in Animal Tests of Anxiety and Depression: Evidence from Genetic Models.

Published in:

Stress: The International Journal on the Biology of Stress, 2003, v. 6, n. 2, p. 101, doi. 10.1080/1025389031000111311

By:

Overstreet, David H.;
Commissaris, Randall C.;
De La Garza II., Richard;
File, Sandra E.;
Knapp, Darin J.;
Seiden, Lewis S.

Publication type:

Article

Monoaminergic system and depression.

Published in:

Cell & Tissue Research, 2019, v. 377, n. 1, p. 107, doi. 10.1007/s00441-018-2978-8

By:

Perez-Caballero, L.;
Torres-Sanchez, S.;
Romero-López-Alberca, C.;
González-Saiz, F.;
Mico, J. A.;
Berrocoso, Esther

Publication type:

Article

Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.

Published in:

Journal of Liposome Research, 2010, v. 20, n. 4, p. 286, doi. 10.3109/08982100903443065

By:

Varshosaz, Jaleh;
Tabbakhian, Majid;
Mohammadi, Mahboobeh Y.

Publication type:

Article

Synthesis of Some Pyrazolo[3, 4]pyrimidine Derivatives for Biological Evaluation.

Published in:

Phosphorus, Sulfur & Silicon & the Related Elements, 2005, v. 180, n. 10, p. 2347, doi. 10.1080/104265090921074

By:

Shamroukh, A. H.;
Rashad, A. E.;
Sayed, H. H.

Publication type:

Article

Worsening psychosis associated with administrations of buspirone and concerns for intranasal administration: A case report S.

Published in:

Frontiers in Psychiatry, 2023, v. 14, p. 01, doi. 10.3389/fpsyt.2023.1129489

By:

Apeldoorn, Samuel;
Chavez, Rebecca;
Haschemi, Freshta;
Elsherif, Kareem;
Weinstein, David;
Torrico, Tyler

Publication type:

Article

Editorial: buspirone for gastroparesis—an intriguing option for a challenging condition.

Published in:

2023

By:

Sayuk, Gregory S.

Publication type:

Editorial

Buspirone for early satiety and symptoms of gastroparesis: A multi‐centre, randomised, placebo‐controlled, double‐masked trial (BESST).

Published in:

Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 11, p. 1272, doi. 10.1111/apt.17479

By:

Parkman, Henry P.;
Yates, Katherine P.;
Sarosiek, Irene;
Bulat, Robert S.;
Abell, Thomas L.;
Koch, Kenneth L.;
Kuo, Braden;
Grover, Madhusudan;
Farrugia, Gianrico;
Silver, Paul;
Abdullah, Amirah;
Maurer, Alan H.;
Malik, Zubair;
Miriel, Laura A.;
Tonascia, James;
Hamilton, Frank;
Pasricha, Pankaj J.;
McCallum, Richard W.

Publication type:

Article

Development and Statistical Optimisation of Buspirone Hydrochloride Buccoadhesive Films.

Published in:

ISRN Otolaryngology, 2014, p. 1, doi. 10.1155/2014/214026

By:

Nagaich, Upendra;
Chaudhary, Vandana;
Nagaich, Jaya

Publication type:

Article

Comparative Evaluation of Efficacy of Oral Diazepam and Buspirone in Reducing Anxiety and Discomfort in Mandibular Third Molar Surgery- In Vivo Study.

Published in:

Indian Journal of Public Health Research & Development, 2019, v. 10, n. 3, p. 66, doi. 10.5958/0976-5506.2019.00483.2

By:

Mitra, Sushmita;
Bhate, Kalyani;
Santhosh kumar, S. N.;
Kshirsagar, Kapil;
Jagtap, Bhagyashree;
Kakodkar, Pradnya

Publication type:

Article

Buspirone Nanovesicular Nasal System for Non-Hormonal Hot Flushes Treatment.

Published in:

Pharmaceutics, 2018, v. 10, n. 3, p. 82, doi. 10.3390/pharmaceutics10030082

By:

Touitou, Elka;
Natsheh, Hiba;
Duchi, Shaher

Publication type:

Article

Effects of Subchronic Buspirone Treatment on Depressive Profile in Socially Isolated Rats: Implication of Early Life Experience on 5-HT1A Receptor-Related Depression.

Published in:

Pharmaceuticals (14248247), 2024, v. 17, n. 6, p. 717, doi. 10.3390/ph17060717

By:

Tzeng, Nian-Sheng;
Chung, Jing-Yi;
Lin, Chen-Cheng;
Cheng, Pao-Yun;
Liu, Yia-Ping

Publication type:

Article

Evaluation of Therapeutic Effect of Buspirone in Improving Dysphagia in Patients with GERD and Ineffective Esophageal Motility: A Randomized Clinical Trial.

Published in:

Gastroenterology Insights, 2023, v. 14, n. 1, p. 1, doi. 10.3390/gastroent14010001

By:

Avanaki, Foroogh Alborzi;
Baghereslami, Elham;
Varpaei, Hesam Aldin;
Farhadi, Narges;
Aletaha, Najmeh;
Allameh, Farshad;
Taher, Mohammad

Publication type:

Article

Methylphenidate increases the urinary excretion of vanillylmandelic acid in rats that is attenuated by buspirone co-administration.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2019, v. 32, p. 895

By:

Alam, Nausheen;
Ikram, Rahila;
Naeem, Sadaf;
Kashif, Sadia Suri;
Siddiqui, Tuba;
Bashir, Lubna;
Naz, Shazia;
Wasi, Nousheen

Publication type:

Article

Methylphenidate-induced hepatotoxicity in rats and its reduction by buspirone.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2018, v. 31, n. 3, p. 741

By:

Alam, Nausheen;
Ikram, Rahila

Publication type:

Article

Buspirone attenuates methylphenidate-induced growth inhibition.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2017, v. 30, n. 2, p. 381

By:

Alam, Nausheen;
Najam, Rahila

Publication type:

Article